Knight Therapeutics Inc. (KHTRF) Financials

KHTRF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 735.4 million 173.3 million
March 31, 2026 781.2 million 215.2 million
Dec. 31, 2025 762.6 million 203.4 million
Sept. 30, 2025 754.1 million 202.7 million

KHTRF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 20.3 million 1.4 million
March 31, 2026 26.7 million 990343
Dec. 31, 2025 24.6 million 2.1 million
Sept. 30, 2025 7.3 million ?

KHTRF Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 -2.4 million
March 31, 2026 9.5 million
Dec. 31, 2025 6.5 million
Sept. 30, 2025 -2.7 million

KHTRF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 85.3 million 4.8 million 7.8 million
March 31, 2026 91.5 million 29.3 million 8.0 million
Dec. 31, 2025 69.4 million 37.3 million 7.3 million
Sept. 30, 2025 68.7 million 56.6 million 4.3 million

KHTRF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 69.1 million
March 31, 2026 70.9 million
Dec. 31, 2025 72.4 million
Sept. 30, 2025 71.6 million

KHTRF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 437082 7.4 million 25.8 million 15.4 million
March 31, 2026 2.4 million 6.8 million 24.8 million 14.6 million
Dec. 31, 2025 368047 6.7 million 25.8 million 14.9 million
Sept. 30, 2025 294867 6.3 million 22.3 million -

KHTRF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 101.5 million 52.5 million
March 31, 2026 106.7 million 67.6 million
Dec. 31, 2025 97.0 million 59.9 million
Sept. 30, 2025 87.4 million 58.4 million

KHTRF

Price: $7.71

52 week price:
4.07
7.71

Earnings Per Share: 0.11 USD

P/E Ratio: 62.25

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 731.8 million

Links: